Shiota Jun
Department of Internal Medicine, Tsunashima Kidney Clinic, Yokohama, Japan.
Kidney Dis (Basel). 2019 Feb;5(1):43-50. doi: 10.1159/000493505. Epub 2018 Oct 9.
Although presepsin (P-SEP) is an early sepsis biomarker, sepsis is often suspected after starting hemodialysis (HD). To enhance the utility of P-SEP, we investigated whether pre-HD P-SEP levels could be predicted using the P-SEP levels from blood samples collected after starting HD.
We observed P-SEP level changes due to HD and dialyzer passage in HD patients using a dialysis membrane with a β-microglobulin (β-MG) clearance of either ≥50 mL/min (high-flux) or < 30 mL/min (intermediate-flux). We calculated the removal ratios for the elimination of P-SEP or the predicted pre-HD P-SEP levels based on the correction of hemoconcentration.
The P-SEP levels significantly decreased at 4 h after starting HD ( = 8) using membranes with a β-MG clearance ≥50 mL/min; the removal ratios at 2 and 4 h were 42.8 ± 7.9% and 58.8 ± 18.4%, respectively. In contrast, the P-SEP levels did not decrease during the passage of dialyzer in 2 patients with a β-MG clearance < 30 mL/min, and the P-SEP levels increased during HD in all patients ( = 10, including the abovementioned 2 patients) with a β-MG clearance < 30 mL/min. The predicted pre-HD P-SEP levels () were strongly correlated with the actually measured pre-HD P-SEP levels () ( = 0.9562) using the regression equation: = 1.0987.
The levels of P-SEP with a molecular weight near that of β-MG decreased similarly to those of β-MG during HD using membranes with a β-MG clearance ≥50 mL/min. On the contrary, the levels of P-SEP rather increased during HD with a β-MG clearance < 30 mL/min, suggesting that P-SEP appeared not to be eliminated. Furthermore, the pre-HD P-SEP levels might be predictable by the correction of hemoconcentration using even blood samples collected after starting HD with a β-MG clearance < 30 mL/min.
尽管可溶性髓系细胞触发受体-1(P-SEP)是早期脓毒症生物标志物,但脓毒症常在开始血液透析(HD)后才被怀疑。为提高P-SEP的实用性,我们研究了能否根据HD开始后采集的血样中的P-SEP水平来预测HD前的P-SEP水平。
我们观察了使用β-微球蛋白(β-MG)清除率≥50 mL/分钟(高通量)或<30 mL/分钟(中通量)的透析膜的HD患者中,HD及透析器通过导致的P-SEP水平变化。我们计算了P-SEP清除的清除率或基于血液浓缩校正的预测HD前P-SEP水平。
使用β-MG清除率≥50 mL/分钟的透析膜时,HD开始后4小时P-SEP水平显著降低(n = 8);2小时和4小时的清除率分别为42.8±7.9%和58.8±18.4%。相比之下,2例β-MG清除率<30 mL/分钟的患者在透析器通过期间P-SEP水平未降低,且所有β-MG清除率<30 mL/分钟的患者(n = 10,包括上述2例患者)在HD期间P-SEP水平升高。使用回归方程:y = 1.0987x,预测的HD前P-SEP水平(y)与实际测量的HD前P-SEP水平(x)高度相关(r = 0.9562)。
使用β-MG清除率≥50 mL/分钟的透析膜进行HD时,分子量与β-MG接近的P-SEP水平与β-MG水平类似地降低。相反,β-MG清除率<30 mL/分钟的HD过程中P-SEP水平反而升高,提示P-SEP似乎未被清除。此外,即使使用β-MG清除率<30 mL/分钟的HD开始后采集的血样,通过血液浓缩校正也可能预测HD前的P-SEP水平。